SCHEMBL16715969

SCHEMBL16715969

CCc1cc(CC)c2ccoc2c1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA2 P16389 1/20 0.36
▸ KDM4E B2RXH2 4/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ POLB P06746 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ MAPT P10636 3/20 0.35
▸ HPGD P15428 3/20 0.35
▸ NOS3 P29474 2/20 0.32
▸ NOS1 P29475 2/20 0.32
▸ NOS2 P35228 2/20 0.32
▸ HTR2A P28223 1/20 0.32
▸ HTR2C P28335 1/20 0.32
▸ HTR2B P41595 1/20 0.32
▸ GABRP O00591 1/20 0.32
▸ GABRD O14764 1/20 0.32
▸ GABRA1 P14867 1/20 0.32
▸ GABRB1 P18505 1/20 0.32
▸ GABRG2 P18507 1/20 0.32
▸ GABRB3 P28472 1/20 0.32
▸ GABRA5 P31644 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15629834 0.86 GAA (0.37) KCNA2KDM4EALDH1A1POLBHTT
SCHEMBL24061869 0.79 PSMD14 (0.39) KDM4EALDH1A1POLBHPGD
SCHEMBL15629833 0.79 HTT (0.35) KCNA2ALDH1A1POLBHTTMAPT
SCHEMBL16091759 0.76 ESR1 (0.34) KCNA2KDM4EALDH1A1POLBMAPT
SCHEMBL22595265 0.76 KCNA2 (0.34) KCNA2KDM4EALDH1A1POLBMAPT
SCHEMBL16091748 0.73 NOS2 (0.37) KCNA2KDM4EALDH1A1POLBMAPT
SCHEMBL4426249 0.70 HTR2A (0.33) KDM4EPOLBHPGDHTR2AHTR2C
SCHEMBL8738096 0.69 KCNA2 (0.36) KCNA2NOS3NOS1NOS2HTR2A
SCHEMBL4416706 0.68 HTR2A (0.32) HTR2AHTR2CHTR2B
SCHEMBL27612200 0.67 HTT (0.50) ALDH1A1POLBHTTMAPTNOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371303-B2 Diphenylmethane derivatives as SGLT2 inhibitors GREEN CROSS CORPORATION (KR) 2016-06-21 — — US disclosed
US-20150152075-A1 NOVEL DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS GREEN CROSS CORPORATION (KR) 2015-06-04 — — US disclosed
US-9034921-B2 Diphenylmethane derivatives as SGLT2 inhibitors GREEN CROSS CORPORATION (KR) 2015-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150152075-A1 NOVEL DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS SLC5A2, SLC5A1, SLC2A8 KCNA2 951/4885KDM4E 1804/4885ALDH1A1 1076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback